Together we can build social capital, enriches transparency, and nurtures a collective trust. Contributing to a heightened sense of participant ownership, which is instrumental in driving research forward in a manner that yields tangible benefits for both individual patients and the broader society.
OncoEng’s ethos is deeply rooted in the active involvement of patients and the public throughout the research continuum.
By co-creating research questions and directions with patient input, OncoEng ensures that the patient voice is not just heard but is also a determinative force in guiding research. The commitment to this collaborative approach is evident in the alignment of research outputs with the real-life experiences of individuals grappling with metastatic bone disease.
Great insight on the patient journey in the NHS. Never knew how many challenges there was to get treatment
– Leeds PhD Students on Patient Day
OncoEng is committed to patient and public involvement at all stages of the research process, co-creating research questions and directions. This enables the patient voice to influence researchers, ensuring that the outputs of research are relevant to the lived experience of people with metastatic bone disease.
If you would like to be involved or kept informed of the progress of this exciting programme of work, please contact either Prof. Richard Hall, PI or Dr Sarah Field, Knowledge Exchange Manager.
Latest News
Using statistical shape models to develop generalised models of vertebrae
Within OncoEng, the team at UCL aims to develop state-of-the-art imaging and computational tools to predict the growth of metastatic lesions and how these can result in fractures in the spine. This involves a variety…
Metamaterials Explored: Our Experience at the 2023 UK Metamaterials Network Conference
This June, Ryan and I had the privilege of attending the UK Metamaterials Network conference at the scenic Wotton House. Over three insightful days, we delved deep into the diverse world of metamaterials, exploring their…
Exploring Metastatic Bone Disease Through Patient Narratives
As a mechanical engineer looking to develop methodologies to characterise spinal biomechanics and its perturbation due to metastatic bone disease (MBD), attending the OncoEng Patient Day was an eye-opening experience. This event provided an invaluable…
Birmingham Med-Tech Innovation Expo 2023
Blog written by Yash Karade and Aamena Lakdawala We bid farewell to Leeds on the morning of 7th June 2023 as we started our journey to the MedTech Expo in Birmingham. It was surely a…
World Cancer Day
The Leeds Cancer Research Centre will be delivering a mini-conference as part of World Cancer Day on the 3 rd February (World Cancer Day is actually on 4th Feb). OncoEng is very supportive of the…
OncoEng Quarterly Meeting
Great OncoEng Quarterly get together last week. The Management Board Meeting in the morning was eagerly attended by all the researchers and academics. In the afternoon we were joined by Dr Sherron Furtado, Craig Gerrand, Sarah Astill and David Lunn to…